This is The Stocks in Action show. First, let's look at ASX 200 and the ASX listed stocks that are trending today.
o The S&P/ASX200 is down just 1.80 points today to 7290.80. The bottom performing stocks in this index are ANSELL down 3.15% and ALTIUM, down 2.63% . Over the last five days, the index has gained 1.01% and is currently 0.60% off of its 52-week high. Post early morning gains, ASX 200 is trending lower around lunch time, tracking subdued Wall Street performance overnight.
• While materials and IT sectors are gaining strength, we can see downtick in consumer and energy indices. Overall, we cannot deny that inflation worries are embedded in investors' psychology. Worries remain that the Fed may start discussing tapering asset purchases at next week's Federal open market committee meeting.
• The ASX 200, which rose 0.5 per cent in early trade, closed firmer at 7,292.6 on Tuesday. The index was led by technology and healthcare stocks. On that note, let us quickly glance through some significant market movements globally. On Tuesday, the three major Wall Street indexes rose, with the big tech stocks traded in the green on Wall Street.
• Crude oil prices surged to two-year high levels on Tuesday due to a delay in Iranian oil supply which was expected to increase the oil gluts in the market.
• August delivery Brent crude oil futures traded 0.03 per cent up at US$70.07 per barrel and whereas, July delivery WTI crude oil futures traded at US$70.08 per barrel up 0.04 per cent as of 9 June 2021 at 10:10 AM AUSTRALIAN EASTERN STANDARD TIME.
• Race Oncology shared that it has executed a contract with Trialog Clinical Trials Ltd, Israel, to support the coming combination Phase 2 Acute Myeloid Leukaemia trial.
• Cellmid announced that its wholly owned consumer health subsidiary, Advangen International has signed a Supply and Collaboration Agreement with Pump Haircare.
• Moving on to the next news BluGlass announced a non-renounceable entitlement offer for shareholders and a private placement of 66.67 million new fully paid ordinary share to raise $2 million at an issue price of 3 cents per new share.
• Brickworks expects building Products EBIT to be higher in Australia and North America in FY2021, with sales gathering momentum.